US 12,226,162 B2
Smart eye mask
Yale Badik, Madison, CT (US); and Deanna Felker, West Hills, CA (US)
Assigned to KURE, LLC, Newark, NJ (US)
Filed by KURE, LLC, Newark, DE (US)
Filed on May 9, 2022, as Appl. No. 17/739,588.
Prior Publication US 2023/0355090 A1, Nov. 9, 2023
Int. Cl. A61B 3/113 (2006.01); A61B 5/00 (2006.01); A61B 5/107 (2006.01); A61F 13/12 (2006.01); G06F 3/01 (2006.01)
CPC A61B 3/113 (2013.01) [A61B 5/1075 (2013.01); A61B 5/4058 (2013.01); A61F 13/124 (2013.01); G06F 3/013 (2013.01)] 16 Claims
OG exemplary drawing
 
1. A system comprising:
an object comprising a mask comprising a first portion to cover an eye of a person, the first portion comprising
a first layer and a second layer adjacent to the first layer, and an eye pocket;
an attachable device; and
a bio-monitoring system comprising a neurological sensor and an acoustic sensor; and
wherein the first layer and the second layer form a pouch;
a control unit comprising a cyber security module;
wherein the system is configured to provide a combination therapy comprising at least two therapies, wherein a first therapy comprises a psychedelic drug therapy;
wherein a second therapy comprises at least one of an aromatherapy, a sound therapy, an acupressure therapy, a massage therapy, a temperature therapy, a magnetic therapy, and a visual based stress relief therapy;
wherein the bio-monitoring system monitors a physiological state of the person in response to the psychedelic drug therapy;
wherein the physiological state comprises a state of body of the person, bodily functions, mental state, and emotional state;
wherein the combination therapy is automatically adjusted based on the physiological state; and
wherein system is configured to adjust the combination therapy by at least one of changing the second therapy, modifying the first therapy, modifying the second therapy, stopping the first therapy, and stopping the second therapy.